Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07202078) titled 'Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Monash University
Condition:
Myeloma
Non Hodgkin'
s Lymphoma
Leukemia
Intervention:
Drug: Trimethoprim / Sulfamethoxazole
Recruitment Status: Recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: May 7, 2025
Target Sample Size: 900
Countries of Recruitment:
Australia
To know more, visit https://...